Email: arturp
fe.up.pt
Phone: +351 22 041 4615
Room: E121
Laboratory: E143
Senior Researcher
Research group: Processes, Products and Energy
Research position: Assistant Researcher
Background: PhD in Biomedical Engineering from Faculty of Engineering, University of Porto, Portugal
Chang H.-P., Silva F.L., Nance E., Fernandes J.R., Santos S.G., Magalhães F.D., Pinto A.M., Incorvia J.A. “SnOx Nanoflakes as Enhanced NIR Photothermal Therapy Agents Synthesized from Electrochemically Oxidized SnS₂ Powders.” ACS Nano 19 (2025): 33749.
Timochenco L., Fernandes P., Ribeirinho-Soares S., Silva F.A.L.S., Freitas B., Nunes O.C., Magalhães F.D., Oliveira M.J., Pinto A.M. “Long-Term Study of Physicochemical Stability, Microbial Contamination, and Endotoxin Levels in UVC-Photoreactor Sterilized Graphene-Based Materials.” Carbon 243 (2025): 120538.
Kurapati R., Swetha K., Samantaray S., Silva F.A.L.S., Silva F.C., Freitas B., Incorvia J.A., Fernandes J.R., Araya J., Banerjee S., Sadananda N.S., Magalhães F.D., Pinto A.M. “Biodegradability of Partially Reduced Nanographene Oxide by Human, Plant and Microbial Enzymes: Impact of Magnetic Nanoparticles.” Carbon 229 (2024): 119486.
Silva F.L., Chang H.-P., Incorvia J.A., Oliveira M.J., Sarmento B., Santos S.G., Magalhães F.D., Pinto A.M. “2D Nanomaterials and Their Drug Conjugates for Phototherapy and Magnetic Hyperthermia Therapy of Cancer and Infections.” Small 20 (2024): 2306137.
Cedillo-Servin G., Dahri O., Meneses J., van Duijn J., Sage F., Silva J., Pereira A., Magalhães F.D., Malda J., Geijsen N., Pinto A.M., Castilho M. “3D Printed Magneto-Active Microfiber Scaffolds for Remote Stimulation of 3D In Vitro Skeletal Muscle Models.” Small 20 (2024): 2307178.
“New Implantable Device for Breast Cancer Phototherapy” (LightCure - 2024.12587.UTA) funded by FCT (93.7K €). Beginning 2025. Duration: 12 months. Partners: i3S (PT), UT Austin (USA), UTAD, Eindhoven University of Technology (NL). Role: Principal Investigator.
“New Pills for Magnetic Hyperthermia combined with Photothermal Therapy of Gastric Cancer” (PowerBotPills - 2023.11891.PEX) funded by FCT (50k€ funding). Beginning 2025. Duration: 18 months. Partners: i3S (PT), UTAD (PT), UT Austin (USA). Role: Principal Investigator.
“New pharmaceutical formulations for rectal cancer phototherapy” (PhotoRect - 2022.04494.PTDC) funded by FCT (50k€ funding). Beginning 2023. Duration: 24 months. Partners: i3S (PT), UT Austin (USA). Role: Principal Investigator.
"New 2D nanomaterials for cancer phototherapy and immunotherapy” (2D-Therapy - POCI-01-0145-FEDER-031143) funded by FCT (93.7K €). Beginning: 2022. Duration: 15 months. Partners: i3S (PT), UT Austin (USA). Role: Principal Investigator.
"New platforms for dermatological phototherapy” (NovaDerma - POCI-01-0145-FEDER-031143) funded by FCT (240K €). Beginning: 2018. Duration: 40 months. Partners: INEB-i3S (PT). Role: Principal Investigator